Neogenomics (NEO) Gross Profit Growth (3y) (2013 - 2026)
Neogenomics (NEO) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 10.79% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.33% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.75% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 94.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.70% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.05% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 15.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.33% |
| Mar 31, 2026 | 13.84% |
| Dec 31, 2025 | 13.62% |
| Sep 30, 2025 | 18.06% |
| Jun 30, 2025 | 20.69% |
| Mar 31, 2025 | 24.20% |
| Dec 31, 2024 | 19.51% |
| Sep 30, 2024 | 16.60% |
| Jun 30, 2024 | 11.01% |
| Mar 31, 2024 | 16.34% |
| Dec 31, 2023 | 5.56% |
| Sep 30, 2023 | 4.85% |
| Jun 30, 2023 | 28.84% |
| Mar 31, 2023 | 5.74% |
| Dec 31, 2022 | 4.41% |
| Sep 30, 2022 | -1.29% |
| Jun 30, 2022 | -3.54% |
| Mar 31, 2022 | -6.73% |
| Dec 31, 2021 | 6.84% |
| Sep 30, 2021 | 13.49% |